Biocon plunges into profit in the third quarter
Bangalore based biotechnology major Biocon has recorded a profit of 81 crores this quarter.
Biocon and HCG Group of Hospitals Ltd. Join Hands to Fight Against Cervical Cancer
Biocon and HCG group of hospitals have announced their partnership to conduct a study to uate the potential benefits of BIOMAb EGFR
Pharma cos recast European operations to protect margins
Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of changing trends in the key market.
Needle-free insulin soon in India
Biotechnology company Shreya Lifesciences has entered into an in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country
